The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.

USTAALIOĞLU, BBBILICI, AERCAN, SSeker, MESUTORCUN, AGUMUS, M2020-10-292020-10-292013-06-01USTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M., -The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.-, Medical oncology (Northwood, London, England), cilt.30, ss.551, 2013http://hdl.handle.net/20.500.12645/26521The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.ArticleWOS:0003194504000598487534357510.1007/s12032-013-0551-6